Pooled Norfolk and Denver subject complete blood counts
| . | HCT (%) . | PLT (×103/μL) . | MPV (fL) . | Donor WBCs (×103/μL) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | |
| Mean | 43 | 42 | 40 | 244 | 247 | 210 | 9.3 | 8.9 | 9.3 | 6.4 | 6.4 | 6.2 |
| SD | 4 | 4 | 3 | 61 | 59 | 49 | 1.3 | 1.0 | 1.1 | 1.7 | 1.3 | 1.5 |
| Min | 36 | 35 | 34 | 141 | 151 | 135 | 7.6 | 7.4 | 7.6 | 3.4 | 4.4 | 3.7 |
| Max | 50 | 50 | 46 | 390 | 374 | 300 | 13.5 | 11.6 | 11.9 | 10.4 | 9.7 | 9.7 |
| . | HCT (%) . | PLT (×103/μL) . | MPV (fL) . | Donor WBCs (×103/μL) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | |
| Mean | 43 | 42 | 40 | 244 | 247 | 210 | 9.3 | 8.9 | 9.3 | 6.4 | 6.4 | 6.2 |
| SD | 4 | 4 | 3 | 61 | 59 | 49 | 1.3 | 1.0 | 1.1 | 1.7 | 1.3 | 1.5 |
| Min | 36 | 35 | 34 | 141 | 151 | 135 | 7.6 | 7.4 | 7.6 | 3.4 | 4.4 | 3.7 |
| Max | 50 | 50 | 46 | 390 | 374 | 300 | 13.5 | 11.6 | 11.9 | 10.4 | 9.7 | 9.7 |
| . | Segmented neutrophils (×103/μL) . | Lymphocytes (×103/μL) . | Monocytes (×103/μL) . | Eosinophils (×103/μL) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | |
| Mean | 3.6 | 3.7 | 3.4 | 1.9 | 2.1 | 2.1 | 0.5 | 0.5 | 0.4 | 0.1 | 0.2 | 0.1 |
| SD | 1.1 | 0.9 | 1.1 | 0.6 | 0.6 | 0.6 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Min | 1.6 | 2.2 | 1.9 | 1.0 | 1.1 | 1.3 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 |
| Max | 6.2 | 5.5 | 5.7 | 3.4 | 3.3 | 3.3 | 0.9 | 0.9 | 0.7 | 0.3 | 0.4 | 0.3 |
| . | Segmented neutrophils (×103/μL) . | Lymphocytes (×103/μL) . | Monocytes (×103/μL) . | Eosinophils (×103/μL) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | Baseline . | Proc1 . | Proc2 . | |
| Mean | 3.6 | 3.7 | 3.4 | 1.9 | 2.1 | 2.1 | 0.5 | 0.5 | 0.4 | 0.1 | 0.2 | 0.1 |
| SD | 1.1 | 0.9 | 1.1 | 0.6 | 0.6 | 0.6 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Min | 1.6 | 2.2 | 1.9 | 1.0 | 1.1 | 1.3 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 |
| Max | 6.2 | 5.5 | 5.7 | 3.4 | 3.3 | 3.3 | 0.9 | 0.9 | 0.7 | 0.3 | 0.4 | 0.3 |
| . | Basophils (×103/μL) . | . | . | . | . | . | . | . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline . | Proc1 . | Proc2 . | ||||||||||
| Mean | 0.0 | 0.0 | 0.0 | |||||||||
| SD | 0.0 | 0.0 | 0.0 | |||||||||
| Min | 0.0 | 0.0 | 0.0 | |||||||||
| Max | 0.1 | 0.1 | 0.1 | |||||||||
| . | Basophils (×103/μL) . | . | . | . | . | . | . | . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline . | Proc1 . | Proc2 . | ||||||||||
| Mean | 0.0 | 0.0 | 0.0 | |||||||||
| SD | 0.0 | 0.0 | 0.0 | |||||||||
| Min | 0.0 | 0.0 | 0.0 | |||||||||
| Max | 0.1 | 0.1 | 0.1 | |||||||||
Norfolk baseline 1 month before entrance to study (February 1999), Denver baseline from March 1999. Complete blood count (CBC) and differential performed on day of apheresis and whole blood collections (Proc1 and Proc2). No significant changes from baseline were observed, except for small increase in mean lymphocyte count (P= .037).
HCT indicates hematocrit; PLT, platelet count; MPV, mean platelet volume. See Tables 1 and 2 for other abbreviations.